Abstract
Purpose:
To build CT perfusion (CTP)-based delta-radiomics models to identify collateral vessel formation after revascularization in patients with moyamoya disease (MMD).
Methods:
Fifty-three MMD patients who underwent CTP and digital subtraction angiography (DSA) examination were retrospectively enrolled. Patients were divided into good and poor groups based on postoperative DSA. CTP parameters, such as mean transit time (MTT), time to drain (TTD), time to maximal plasma concentration (Tmax), and flow extraction product (FE), were obtained. CTP efficacy in evaluating surgical treatment were compared between the good and poor groups. The changes in the relative CTP parameters (ΔrMTT, ΔrTTD, ΔrTmax, and ΔrFE) were calculated to evaluate the differences between pre- and postoperative CTP values. CTP parameters were selected to build delta-radiomics models for identifying collateral vessel formation. The identification performance of machine learning classifiers was assessed using area under the receiver operating characteristic curve (AUC).
Results:
Of the 53 patients, 36 (67.9%) and 17 (32.1%) were divided into the good and poor groups, respectively. The postoperative changes of ΔrMTT, ΔrTTD, ΔrTmax, and ΔrFE in the good group were significantly better than the poor group (p < 0.05). Among all CTP parameters in the perfusion improvement evaluation, the ΔrTTD had the largest AUC (0.873). Eleven features were selected from the TTD parameter to build the delta-radiomics model. The classifiers of the support vector machine and k-nearest neighbors showed good diagnostic performance with AUC values of 0.933 and 0.867, respectively.
Conclusion:
The TTD-based delta-radiomics model has the potential to identify collateral vessel formation after the operation.
Introduction
Moyamoya disease (MMD), also known as spontaneous occlusion of the circle of Willis, is a non-atherosclerotic progressive steno-occlusive arteriopathy first reported by . It most frequently affects the internal carotid arteries, proximal segments of the middle cerebral arteries (MCAs), and anterior cerebral arteries, accompanied by a tuft of collateral vessels at the base of the brain. Revascularization could mitigate the risk of future ischemic events or MMD rebleeding (; ). Thus, surgical interventions are recommended once the MMD diagnosis is clear (; ). Revascularization can immediately improve cerebral blood flow. Superficial temporal artery–MCA anastomosis is most commonly used in clinical practice (; ).
Perfusion imaging provides an assessment of the territory at risk for infarct from hypoperfusion and serves a key role in making surgical decision for MMD. CT perfusion (CTP), as a fast, feasible, and multiparameter imaging modality, has been widely used in cerebral hemodynamic evaluation of MMD (; ; ). After revascularization, digital subtraction angiography (DSA) is the reference standard for evaluating the patency of the bypass and collateral vessel formation (). However, limited by multiple factors (e.g., invasive nature, radiation exposure, and perioperative complications), DSA is sometimes given more careful consideration (). In recent years, artificial intelligence with radiomics as the core has made breakthroughs in computer-aided diagnosis, staging, and prognosis of diseases (; ; ; ). Radiomics has the advantages of intelligence, multiple parameters, and objective quantification (). Delta-radiomics introduces a time component and shows the changes in radiomics features from pre- to post-treatment and is suitable for evaluating the treatment response ().
Studies on automated detection of MMD based on machine learning have been recently noted (; ; ; ). However, no published studies have focused on radiomics in predicting MMD treatment outcomes after revascularization. Therefore, this study aims to (1) evaluate the CTP efficacy to assess the perfusion changes before and after revascularization and (2) further build the delta-radiomics models to identify the formation of collateral vessels after the operation.
Materials and methods
Patients
This retrospective study was approved by the local institutional review board, and the requirement for informed consent was waived. The MMD patients, based on the diagnostic guidelines of the Research Committee of MMD of the Japanese Ministry of Health (), were enrolled from June 2016 to March 2020 (Figure 1). The participation eligibility was established following the inclusion criteria: (1) the CTP and DSA were performed before and after surgery, (2) the surgical method was direct revascularization surgery. The exclusion criteria were as follows: (1) the hemisphere had undergone other surgery before revascularization and (2) the CTP data was incomplete or missing. After revascularization, DSA and CTP examinations were scheduled for patients at 6 months follow-up.
FIGURE 1
Angiographic evaluation
The angiographic stages of the MMD patients were evaluated by DSA. All images were assessed by two radiologists (JL and YZ, with 8 and 10 years of experience, respectively). The collateral vessels were classified into four grades according to the extent of collateral vessel formation by modification of the Matsushima grade () (grade 0, no clear collaterals; grades 1, less than one-third of the MCA distribution; grade 2, between two-thirds and one-third of the MCA distribution; and grade 3, more than two-thirds of the MCA distribution). Grades 2 and 3 were classified as the good group, and grades 1 and 0 were classified as the poor group.
CT scanning and processing of CT perfusion data
The CTP was performed using the third-generation dual-source CT scanner (Somatom Force, Siemens Healthcare, Forchheim, Germany). Routine brain scanning was done, and DynMulti 4D scan mode (shuttle scan mode, Siemens Healthcare) was used for volume perfusion computer tomography. A 50-ml bolus of contrast media iopromide (Ultravist 370 mg L/ml; Bayer Schering Pharma, Berlin, Germany) was administered into an antecubital vein using a power injector (Ulrich Injection System, Germany) with an injection rate of 5 ml/s. Eighteen dynamic CT scans were initiated 5 s after the start of the contrast material injection. The scanning parameters were as follows: 70 kV tube voltage, 200 mA tube current, collimator 128 mm × 0.6 mm, 1.5 mm slice thickness, and 0.25 s rotation time.
CT perfusion source data were transferred to the Syngo workstation (Siemens Syngo.via, VA20A). The data source was analyzed using CT Neuro-Perfusion software. The cerebral artery that first reached the enhanced peak was selected as the input artery. The superior sagittal sinus was selected as the output vein. Perfusion parameter maps were generated via an automatic delay-insensitive deconvolution algorithm (). Parameter maps for cerebral blood flow (CBF), cerebral blood volume (CBV), time to drain (TTD), mean transit time (MTT), time to maximal plasma concentration (Tmax), and flow extraction product (FE) were obtained.
For quantitative analysis, the Tmax > 6 s was used as the threshold to define the ischemic hypoperfusion area (). Regions of interest (ROIs) were drawn in the largest cross-sectional area of the abnormal perfusion. The range of ROIs covered the complete perfusion abnormalities over the cortical MCA distribution. Previous hemorrhage and infarcted lesions were avoided in the ROI. Contralateral mirror ROIs were automatically acquired. The average value was taken after two measurements. The relative CTP values (e.g., rCBF, rCBV, rMTT, rTTD, rTmax, and rFE) were defined as the ratios between absolute CTP values of the surgical and contralateral sides. An attempt was made to draw the same ROIs in the same location for one patient before and after the revascularization as shown in a previous study ().
To compare variation between the preoperative and postoperative perfusion parameters, the relative CTP parameter changes were calculated as follows: ΔrCBF = rCBFpost - rCBFpre, ΔrCBV = rCBVpost - rCBVpre, ΔrMTT = rMTTpre - rMTTpost, ΔrTTD = rTTDpre - rTTDpost, ΔrTmax = rTmaxpre - rTmaxpost, ΔrFE = rFEpre - rFEpost, where Δ, pre, and post indicate CTP parameter change, before surgery, and after surgery, respectively.
Radiomics workflow
The workflow of the delta-radiomics analysis included ROI segmentation, feature extraction, feature reduction and selection, and model construction.
ROIs segmentation
Two experienced radiologists (with 7 and 15 years of CT diagnosis experience) performed the segmentation using the open-source software ITK-SNAP (version 3.8.01). The ROIs were contoured from both the preoperative and postoperative CTP maps. An attempt was made to draw the same ROIs as the CTP data processing.
Feature extraction
Feature extraction was performed using RadCloud V.2.2 (Huiying Medical Technology Co., Ltd., Beijing, China). The largest cross-sectional area of the abnormal perfusion was used as the ROI, and the shape-based features were deleted. Of the features, 1,395 were extracted (Supplementary Table 1). The radiomics features were divided into three groups: (a) first-order statistics (126 features), which quantitatively delineated the distribution of voxel intensities within ROIs; (b) textural features (525 features), which were calculated from gray-level run-length matrix, gray-level co-occurrence matrix, gray-level size zone matrix, gray-level dependence matrix, and neighborhood gray-tone difference matrix; (c) wavelet-transformed features (744 features), which included the intensity and texture features derived from wavelet transformation of the original images, processed using filters (e.g., wavelet-LLL, wavelet-LLH, wavelet-LHL, wavelet-LHH, wavelet-HLL, wavelet-HLH, wavelet-HHL, and wavelet-HHH). Delta-radiomics (an example was shown in Supplementary material 1) was defined as the changes in radiomics features pre- and postoperatively during treatment and calculated as follows:
Radiomic feature reduction and selection
The intraclass correlation coefficient calculated from all the patients was used to improve the reproducibility of the radiomic features (). Features with intraclass correlation coefficient values > 0.75 were retained for subsequent analysis. All radiomics features were standardized into normal distribution with z-score normalization. Then, the independent t-test with Bonferroni corrected p-values was used to test whether the radiomics features were different between the good and poor collateral formation groups. Finally, the least absolute shrinkage and selection operator (LASSO) algorithm was performed to select the radiomic features. Tenfold cross-validation was used in determining the tuning parameter λ. Some feature coefficients were reduced to zero by tuning the λ. The non-zero coefficient features were selected.
Radiomics model construction
Two classifiers with machine learning algorithms (support vector machine, SVM; k-nearest neighbors, KNN) were trained for model construction and validated in the training and validation cohorts, respectively. Details of parameters used in machine learning were shown in Supplementary Table 2. The diagnostic performance of the models was evaluated by accuracy, precision, recall, F1 score, and area under the receiver operating characteristic (ROC) curve (AUC) compared with Delong’s test.
Statistical analysis
Statistical analysis was performed using SPSS statistical software (version 18.0, SPSS Inc., Chicago, IL, United States) and Python software.2 Qualitative variables were in n (%) and analyzed using Chi-square test, whereas quantitative variables were in mean ± SD and analyzed using t-test. Paired t-test and two-sample t-test were used to analyze differences. ROC curves were constructed to explore the efficacy of CTP parameters and machine learning classifiers. All statistical tests were two-sided, and p < 0.05 indicates a significant difference.
Results
Patient characteristics
The mean follow-up was 8.2 ± 3.5 months. Fifty-three patients with MMD fulfilled the inclusion and exclusion criteria. The demographic and clinical information of patients are shown in Table 1. All patients were randomly divided into the training (n = 42) and test (n = 11) cohorts. No significant differences were found in patient characteristics between the training and validation cohorts (Supplementary Table 3).
TABLE 1
| Variables | Patients (n = 53) |
| Age, years* | 41.5 ± 12.1(12–62) |
| Gender | |
| Male | 22 (41.5%) |
| Female | 31(58.5%) |
| Preoperative clinical symptoms | |
| Ischemia | 16 (30.2%) |
| TIA | 8 (15.1%) |
| Infarction | 19 (35.8%) |
| Hemorrhage | 10 (18.9%) |
| Lesion type | |
| Bilateral | 40 (75.5%) |
| Unilateral | 13 (24.5%) |
| Postoperative follow-up, months | 8.2 ± 3.5 (3–24) |
| Suzuki stages | |
| Stage 1 | 0 |
| Stage 2 | 1 (1.9%) |
| Stage 3 | 26 (49.1%) |
| Stage 4 | 24 (45.3%) |
| Stage 5 | 2 (3.8%) |
| Stage 6 | 0 |
| Grades for collateral vessel formation after operation | |
| Grade 0 | 2 (3.8%) |
| Grade 1 | 15 (28.3%) |
| Grade 2 | 26 (49.1%) |
| Grade 3 | 10 (18.9%) |
Clinical information of patients with MMD.
TIA, transient ischemic attack.
*Qualitative variables are in n (%), whereas quantitative variables are in mean ± SD, with ranges in parentheses.
Patency of the anastomoses and formation of collateral vessels
The patency of the anastomoses was evaluated by DSA. Fifty (94.3%) cases showed patency of the bridging vessels (Figure 2), whereas three cases (5.7%) were occluded. Among the 53 patients with collateral vessels formation grade classification, 10 (18.9%), 26 (49.1%), 15 (28.3%), and two (3.8%) cases were grades 3, 2, 1, and 0, respectively. Moreover, 36 and 17 cases were classified into good and poor groups, respectively. Additionally, the patient characteristics of the good and poor groups are presented in Supplementary Table 4.
FIGURE 2
CT perfusion evaluations
Six perfusion maps (CBF, CBV, MTT, TTD, Tmax, and FE) were obtained (Table 2 and Figure 2). Compared with preoperative parameters, the results showed that the absolute CBF and rCBF values of the surgical side increased significantly after operation (pCBF = 0.023, prCBF < 0.001), whereas the MTT, TTD, Tmax, FE, and their relative values reduced significantly (pMTT, pTTD, pTmax, prMTT, prTTD, and prTmax < 0.001, pFE = 0.005, prFE = 0.002). In addition, no significant difference was noted in CBV and rCBV before and after operation (pCBV = 0.351, prCBV = 0.002).
TABLE 2
| Pre-operation | Post-operation | t-value | P-value | |
| CBF (ml.100 g–1.min–1) | 49.260 ± 21.614 | 55.671 ± 17.193 | –2.337 | 0.023 |
| CBV (ml.100 g–1) | 3.595 ± 2.051 | 3.339 ± 0.923 | 0.941 | 0.351 |
| MTT (s) | 5.559 ± 1.225 | 4.381 ± 0.754 | 6.86 | < 0.001 |
| TTD (s) | 8.033 ± 2.524 | 5.523 ± 1.831 | 7.755 | < 0.001 |
| Tmax (s) | 5.263 ± 2.077 | 3.352 ± 1.513 | 7.293 | < 0.001 |
| FE(ml.100 g–1.min–1) | 2.035 ± 1.861 | 1.181 ± 1.209 | 2.902 | 0.005 |
| rCBF | 0.848 ± 0.246 | 0.986 ± 0.206 | –4.453 | < 0.001 |
| rCBV | 1.001 ± 0.227 | 0.987 ± 0.189 | 0.451 | 0.654 |
| rMTT | 1.305 ± 0.258 | 1.028 ± 0.190 | 7.507 | < 0.001 |
| rTTD | 1.739 ± 0.806 | 1.195 ± 0.519 | 5.840 | < 0.001 |
| rTmax | 2.215 ± 1.607 | 1.408 ± 0.904 | 4.372 | < 0.001 |
| rFE | 2.385 ± 2.622 | 1.194 ± 0.746 | 3.215 | 0.002 |
Comparison of CTP values of surgical side before and after operation (mean ± SD).
CBF, cerebral blood flow; CBV, cerebral blood volume; TTD, time to drain; MTT, mean transit time; Tmax, time to maximal plasma concentration; FE, flow extraction product.
The perfusion improvement between good and poor collateral vessel groups was also compared. The ΔrMTT, ΔrTTD, ΔrTmax, and ΔrFE in the good group were significantly better than those in the poor group (Table 3). However, no statistically significant difference was noted in the ΔrCBF between the two groups. In the ROC curve analysis of the efficacy of the CTP parameters, ΔrTTD had the largest AUC (0.873) among all parameters with a diagnostic sensitivity and specificity of 72.2% and 94.1%, respectively (Figure 3).
TABLE 3
| ΔrCBF | ΔrCBV | ΔrMTT | ΔrTTD | ΔrTmax | ΔrFE | |
| Good group(n = 36) | 0.164 ± 0.238 | –0.07 ± 0.229 | 0.357 ± 0.270 | 0.823 ± 0.634 | 1.056 ± 1.554 | 1.723 ± 3.116 |
| Poor group(n = 17) | 0.085 ± 0.194 | 0.105 ± 0.169 | 0.105 ± 0.163 | 0.193 ± 0.152 | 0.281 ± 0.384 | 0.061 ± 0.633 |
| t-value | –1.184 | –2.806 | –3.556 | –5.629 | –2.815 | –3.070 |
| p-value | 0.242 | 0.007 | 0.001 | < 0.001 | 0.007 | 0.004 |
Comparison of ΔrCTP values before and after operation between good and poor groups.
ΔrCTP, the changes in the relative CTP parameters; CBF, cerebral blood flow; CBV, cerebral blood volume; TTD, time to drain; MTT, mean transit time; Tmax, time to maximal plasma concentration; FE, flow extraction product.
FIGURE 3
Radiomic feature selection
After the reproducibility analysis, 1,156 features were left. Using independent t-test and LASSO regression model analysis (Figure 4), 11 features were finally left (Figure 5).
FIGURE 4
FIGURE 5
Diagnostic performance of radiomics models
The performance of the two feature classifiers for the identification of collateral vessel formation is shown in Table 4. The AUC values of SVM and KNN were 0.933 (95% CI, 0.618–0.999) and 0.867 (95% CI, 0.536–0.991), respectively (Figure 6). No significant difference was noted between SVM and KNN classifiers (p = 0.394).
TABLE 4
| Accuracy | Precision | Recall | F1 score | AUC (95% CI) | |
| SVM | 0.818 | 0.750 | 1.000 | 0.857 | 0.933 (0.618–0.999) |
| KNN | 0.636 | 0.667 | 0.667 | 0.667 | 0.867 (0.536–0.991) |
Performance of the two feature classifiers for the prediction of collateral vessels formation after revascularization in moyamoya disease.
SVM support vector machine, KNN k-nearest neighbors, AUC area under the curve.
FIGURE 6
Discussion
Extracranial–intracranial bypass surgery has been widely used in MMD treatment since the first superficial temporal artery-MCA anastomosis was performed by Yasargil in 1967 (). Traditionally, the surgical outcome was evaluated by DSA. The present study explored whether machine learning could be used to identify collateral vessel formation. Through the analysis of CTP parameters and construction of delta-radiomics models, hemodynamics improvement after revascularization at the surgical side could be evaluated by CTP, and the radiomics models could non-invasively identify collateral vessel formation, where the AUC values of SVM and KNN were 0.933 and 0.867, respectively.
This study adopted the third-generation dual-source CT with DynMulti 4D scan mode. Whole-brain CTP, which can reflect cerebral microcirculation information, was scanned in a single examination with fast scanning speed and low radiation dose (). This study used the Syngo.via to process the CTP images. It used the same delay-insensitive deconvolution algorithm with the reference standard CTP software RAPID (iSchema View inc., Menlo Park, CA, United States) (). The study found that the rCBF value of the surgical side significantly increased after the operation, while the rMTT, rTTD, rTmax, and rFE values significantly reduced. This finding was consistent with previous research (; ). In the present study, other CTP parameters (e.g., Tmax and FE) were also evaluated. Tmax is the time to the maximum of the tissue residue function. It is an important parameter to differentiate the infarction core from the penumbral tissues (); the optimal threshold for early identification of hypoperfused tissue is between 4 and 6 s (). The preoperative and postoperative mean Tmax values on the surgical side for total sets in the current study were 5.263 ± 2.077 s and 3.352 ± 1.513 s, respectively (p < 0.05). It demonstrated that the ischemic area decreased after revascularization. FE reflects the efflux rate (permeability) from intravenous to extravenous (), generally regarded as a marker of blood–brain barrier (BBB) disturbance (). The BBB permeability increases in cerebral ischemia, and the BBB is impaired in MMD patients (). The absolute and relative values of FE on the surgical side were significantly decreased after revascularization in the current study. This suggested that the BBB was repaired after the revascularization. The parameters through quantitative analysis showed that ischemic cerebral tissue perfusion improved after revascularization. The improvement of cerebral perfusion between the good and the poor groups was further compared after the bypass operation. The postoperative changes in ΔrMTT, ΔrTTD, ΔrTmax, and ΔrFE of the good group were significantly greater than that of the poor group (p < 0.05). In addition, this study found that ΔrTTD had the highest efficacy in evaluating the cerebral perfusion improvement, and it may be the most sensitive parameter to evaluate cerebral perfusion. TTD is defined as the time to start + MTT and represents the time in which the contrast agent moves away from the analyzed voxel (; ; ). Thus, it is well-suited to delineate the extent of ischemic lesions.
Radiomics was first proposed by . Delta-radiomics analysis shows the changes in radiomics features between baseline and follow-up examinations during treatment. This study is believed to be the first to use CTP-based delta-radiomics features to identify collateral vessel formation after revascularization. In the present study, the radiomics changes in MMD before and after revascularization reflected the treatment response. Two machine learning classifiers were trained to identify the formation of collateral vessels. The results showed that the classifiers SVM and KNN had good diagnostic performance with AUC values 0.933 and 0.867, respectively, and no difference was noted between the AUC of SVM and KNN (p = 0.394). The algorithms of SVM and KNN are widely used in machine learning (; ). In the present study, the first important radiomics feature was square_firstorder_InterquartileRange. It is a first-order feature and reflects changes in the image array intensity. A previous study found that texture features such as Entropy, uniformity, kurtosis, skewness, and standard deviation of the pixel distribution histogram were correlated with clinical outcomes (). These results implied that the endangered brain tissue was reperfused after vascular anastomosis, and thus led to the intensity and texture change in this area.
The present study had some limitations. The sample size was relatively small. Multicenter prospective studies with a larger set of clinical data are necessary to validate the radiomics model. In addition, the radiomic features extracted in this study were based on two-dimensional (2D) images. Ideally, three-dimensional (3D) image feature extraction should be performed. The study of found that the 2D and 3D CT texture results were fairly similar. In addition, there were previous studies used the 2D ROIs to build the radiomics and achieved good performance (; ).
Conclusion
CT perfusion could quantitatively access the cerebral hemodynamic changes in MMD before and after revascularization, and TTD maps was the most sensitive parameter in evaluating the cerebral perfusion improvement after revascularization in patients with MMD. The TTD-based delta-radiomics model has the potential to identify collateral vessel formation after the operation, and it may serve as an alternative way to evaluating the MMD revascularization outcomes.
Statements
Data availability statement
The original contributions presented in this study are included in the article/Supplementary material, further inquiries can be directed to the corresponding author.
Ethics statement
This study was approved by the Ethical Review Committee of the Shandong Provincial Qianfoshan Hospital. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.
Author contributions
JL wrote original draft preparation and design. KL, TJ, DY, ML, and YC collected the data. YZ, CF, JP, and HS analyzed the data and built the prediction models. QZ revised the manuscript. All authors contributed to the article and approved the submitted version.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnins.2022.974096/full#supplementary-material
References
1
AbelsB.KlotzE.TomandlB. F.KloskaS. P.LellM. M. (2010). Perfusion CT in acute ischemic stroke: a qualitative and quantitative comparison of deconvolution and maximum slope approach.Am. J. Neuroradiol.311690–1698. 10.3174/ajnr.A2151
2
AckerG.FekonjaL.VajkoczyP. (2018). Surgical management of moyamoya disease.Stroke49476–482. 10.1161/STROKEAHA.117.018563
3
AkiyamaY.MikamiT.MikuniN. (2020). Deep learning-based approach for the diagnosis of moyamoya disease.J. Stroke Cerebrovasc. Dis.29:105322. 10.1016/j.jstrokecerebrovasdis.2020.105322
4
ArendtC. T.LeithnerD.MayerhoeferM. E.GibbsP.CzernyC.ArnoldnerC.et al (2021). Radiomics of high-resolution computed tomography for the differentiation between cholesteatoma and middle ear inflammation: effects of post-reconstruction methods in a dual-center study.Eur. Radiol.314071–4078. 10.1007/s00330-020-07564-4
5
BendszusM.KoltzenburgM.BurgerR.Warmuth-MetzM.HofmannE.SolymosiL. (1999). Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective study.Lancet3541594–1597. 10.1016/s0140-6736(99)07083-x
6
ChenY.XuW.GuoX.ShiZ.SunZ.GaoL.et al (2016). CT perfusion assessment of Moyamoya syndrome before and after direct revascularization (superficial temporal artery to middle cerebral artery bypass).Eur. Radiol.26254–261. 10.1007/s00330-015-3802-4
7
DongF.LiQ.JiangB.ZhuX.ZengQ.HuangP.et al (2020). Differentiation of supratentorial single brain metastasis and glioblastoma by using peri-enhancing oedema region-derived radiomic features and multiple classifiers.Eur. Radiol.303015–3022. 10.1007/s00330-019-06460-w
8
ElhalawaniH.LinT. A.VolpeS.MohamedA. S. R.WhiteA. L.ZafereoJ.et al (2018). Machine learning applications in head and neck radiation oncology: lessons from open-source radiomics challenges.Front. Oncol.8:294. 10.3389/fonc.2018.00294
9
FangX. K.NiQ. Q.SchoepfU. J.ZhouC. S.ChenG. Z.LuoS.et al (2016). Image quality, radiation dose and diagnostic accuracy of 70 kVp whole brain volumetric CT perfusion imaging: a preliminary study.Eur. Radiol.264184–4193. 10.1007/s00330-016-4225-6
10
GilliesR. J.KinahanP. E.HricakH. (2016). Radiomics: images are more than pictures, they are data.Radiology278563–577. 10.1148/radiol.2015151169
11
GuD.HuY.DingH.WeiJ.ChenK.LiuH.et al (2019). CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.Eur. Radiol.296880–6890. 10.1007/s00330-019-06176-x
12
GuoX.YuanX.GaoL.ChenY.YuH.ChenW.et al (2021). Encephaloduroarteriosynangiosis (EDAS) treatment of moyamoya syndrome: evaluation by computed tomography perfusion imaging.Eur. Radiol.318364–8373. 10.1007/s00330-021-07960-4
13
HuangY. Q.LiangC. H.HeL.TianJ.LiangC. S.ChenX.et al (2016). Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer.J. Clin. Oncol.342157–2164. 10.1200/JCO.2015.65.9128
14
HwangI.ChoW. S.YooR. E.KangK. M.YooD. H.YunT. J.et al (2020). Revascularization evaluation in adult-onset moyamoya disease after bypass surgery: superselective arterial spin labeling perfusion MRI compared with digital subtraction angiography.Radiology297630–637. 10.1148/radiol.2020201448
15
KangK.MaN.LiJ.ShenY.GuW.MaG.et al (2020). Cerebral hemodynamic changes after revascularization in patients with hemorrhagic moyamoya disease.Front. Neurol.11:72. 10.3389/fneur.2020.00072
16
KimT.HeoJ.JangD. K.SunwooL.KimJ.LeeK. J.et al (2019). Machine learning for detecting moyamoya disease in plain skull radiography using a convolutional neural network.EBioMedicine40636–642. 10.1016/j.ebiom.2018.12.043
17
KimT.OhC. W.BangJ. S.KimJ. E.ChoW. S. (2016a). Moyamoya disease: treatment and outcomes.J. Stroke1821–30. 10.5853/jos.2015.01739
18
KimT.OhC. W.KwonO. K.HwangG.KimJ. E.KangH. S.et al (2016b). Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.J. Neurosurg.1241788–1793. 10.3171/2015.6.JNS151105
19
KooT. K.LiM. Y. (2016). A guideline of selecting and reporting intraclass correlation coefficients for reliability research.J. Chiropr. Med.15155–163. 10.1016/j.jcm.2016.02.012
20
LambinP.LeijenaarR. T. H.DeistT. M.PeerlingsJ.de JongE. E. C.van TimmerenJ.et al (2017). Radiomics: the bridge between medical imaging and personalized medicine.Nat. Rev. Clin. Oncol.14749–762. 10.1038/nrclinonc.2017.141
21
LambinP.Rios-VelazquezE.LeijenaarR.CarvalhoS.van StiphoutR. G.GrantonP.et al (2012). Radiomics: extracting more information from medical images using advanced feature analysis.Eur. J. Cancer48441–446. 10.1016/j.ejca.2011.11.036
22
LeeY. (2010). Support vector machines for classification: a statistical portrait.Methods Mol. Biol.620347–368. 10.1007/978-1-60761-580-4_11
23
LeiY.ZhangX.NiW.YangH.SuJ. B.XuB.et al (2021). Recognition of moyamoya disease and its hemorrhagic risk using deep learning algorithms: sourced from retrospective studies.Neural Regen. Res.16830–835. 10.4103/1673-5374.297085
24
LiJ.JinM.SunX.LiJ.LiuY.XiY.et al (2019). Imaging of moyamoya disease and moyamoya syndrome: current status.J. Comput. Assist. Tomogr.43257–263. 10.1097/RCT.0000000000000834
25
LubnerM. G.StaboN.LubnerS. J.del RioA. M.SongC.HalbergR. B.et al (2015). CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes.Abdom. Imaging402331–2337. 10.1007/s00261-015-0438-4
26
MatsushimaT.InoueT.SuzukiS. O.FujiiK.FukuiM.HasuoK. (1992). Surgical treatment of moyamoya disease in pediatric patients–comparison between the results of indirect and direct revascularization procedures.Neurosurgery31401–405. 10.1227/00006123-199209000-00003
27
MiyamotoS.YoshimotoT.HashimotoN.OkadaY.TsujiI.TominagaT.et al (2014). Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial.Stroke451415–1421. 10.1161/STROKEAHA.113.004386
28
MuehlenI.SprugelM.HoelterP.HockS.KnottM.HuttnerH. B.et al (2021). Comparison of two automated computed tomography perfusion applications to predict the final infarct volume after thrombolysis in cerebral infarction 3 recanalization.Stroke531657–1664. 10.1161/STROKEAHA.121.035626
29
NarducciA.YasuyukiK.OnkenJ.BlecharzK.VajkoczyP. (2019). In vivo demonstration of blood-brain barrier impairment in Moyamoya disease.Acta Neurochir.161371–378. 10.1007/s00701-019-03811-w
30
NarisawaA.FujimuraM.TominagaT. (2009). Efficacy of the revascularization surgery for adult-onset moyamoya disease with the progression of cerebrovascular lesions.Clin. Neurol. Neurosurg.111123–126. 10.1016/j.clineuro.2008.09.022
31
NgF.GaneshanB.KozarskiR.MilesK. A.GohV. (2013). Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival.Radiology266177–184. 10.1148/radiol.12120254
32
OlivotJ. M.MlynashM.ThijsV. N.KempS.LansbergM. G.WechslerL.et al (2009). Optimal Tmax threshold for predicting penumbral tissue in acute stroke.Stroke40469–475. 10.1161/STROKEAHA.108.526954
33
OthmanA. E.AfatS.NikoubashmanO.MullerM.SchubertG. A.BierG.et al (2016). Volume perfusion CT imaging of cerebral vasospasm: diagnostic performance of different perfusion maps.Neuroradiology58787–792. 10.1007/s00234-016-1695-9
34
Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, and Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases (2012). Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis).Neurol. Med. Chir.52245–266. 10.2176/nmc.52.245
35
RobertsH. C.RobertsT. P.BraschR. C.DillonW. P. (2000). Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade.AJNR Am. J. Neuroradiol.21891–899.
36
ShiZ.MaG.ZhangD. (2021). Haemodynamic analysis of adult patients with moyamoya disease: CT perfusion and DSA gradings.Stroke Vasc. Neurol.641–47. 10.1136/svn-2019-000317
37
ShihL. C.SaverJ. L.AlgerJ. R.StarkmanS.LearyM. C.VinuelaF.et al (2003). Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue.Stroke341425–1430. 10.1161/01.STR.0000072998.70087.E9
38
SuzukiJ.TakakuA. (1969). Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain.Arch. Neurol.20288–299. 10.1001/archneur.1969.00480090076012
39
VulcuS.WagnerF.SantosA. F.ReitmeirR.SollN.SchoniD.et al (2019). Repetitive computed tomography perfusion for detection of cerebral vasospasm-related hypoperfusion in aneurysmal subarachnoid hemorrhage.World Neurosurg.121e739–e746. 10.1016/j.wneu.2018.09.208
40
WaddleS. L.JuttukondaM. R.LantsS. K.DavisL. T.ChitaleR.FuscoM. R.et al (2020). Classifying intracranial stenosis disease severity from functional MRI data using machine learning.J. Cereb. Blood Flow Metab.40705–719. 10.1177/0271678X19848098
41
XydaA.HaberlandU.KlotzE.BockH. C.JungK.KnauthM.et al (2011). Brain volume perfusion CT performed with 128-detector row CT system in patients with cerebral gliomas: a feasibility study.Eur. Radiol.211811–1819. 10.1007/s00330-011-2150-2
42
YasargilM. G.YonekawaY. (1977). Results of microsurgical extra-intracranial arterial bypass in the treatment of cerebral ischemia.Neurosurgery122–24. 10.1227/00006123-197707000-00005
43
Zaro-WeberO.FleischerH.ReiblichL.SchusterA.Moeller-HartmannW.HeissW. D. (2019). Penumbra detection in acute stroke with perfusion magnetic resonance imaging: validation with (15) O-positron emission tomography.Ann. Neurol.85875–886. 10.1002/ana.25479
44
ZhangG.XuL.ZhaoL.MaoL.LiX.JinZ.et al (2020). CT-based radiomics to predict the pathological grade of bladder cancer.Eur. Radiol.306749–6756. 10.1007/s00330-020-06893-8
45
ZhangJ.WangJ.GengD.LiY.SongD.GuY. (2013). Whole-brain CT perfusion and CT angiography assessment of Moyamoya disease before and after surgical revascularization: preliminary study with 256-slice CT.PLoS One8:e57595. 10.1371/journal.pone.0057595
46
ZhouJ.TanH.BaiY.LiJ.LuQ.ChenR.et al (2019). Evaluating the HER-2 status of breast cancer using mammography radiomics features.Eur. J. Radiol.121:108718. 10.1016/j.ejrad.2019.108718
Summary
Keywords
perfusion imaging, moyamoya disease, cerebral revascularization, delta-radiomics, machine learning
Citation
Li J, Zhang Y, Yin D, Shang H, Li K, Jiao T, Fang C, Cui Y, Liu M, Pan J and Zeng Q (2022) CT perfusion-based delta-radiomics models to identify collateral vessel formation after revascularization in patients with moyamoya disease. Front. Neurosci. 16:974096. doi: 10.3389/fnins.2022.974096
Received
20 June 2022
Accepted
20 July 2022
Published
11 August 2022
Volume
16 - 2022
Edited by
Mario Sansone, University of Naples Federico II, Italy
Reviewed by
Anna Podlasek, University of Dundee, United Kingdom; Stefano Marrone, University of Naples Federico II, Italy
Updates
Copyright
© 2022 Li, Zhang, Yin, Shang, Li, Jiao, Fang, Cui, Liu, Pan and Zeng.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qingshi Zeng, zengqingshi@sina.com
This article was submitted to Brain Imaging Methods, a section of the journal Frontiers in Neuroscience
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.